Table 1.

Characteristics of Primary Care Patients in 6 Healthcare Systems by HCV and HIV Status

	HCV alone	HIV alone	Both HCV and HIV	Neither HCV nor HIV
Characteristics	n = 10,042	n = 5821	n = 422	n = 1352,319
Age, years	%
18–25	1.7	4.0	1.2	10.4
26–35	3.5	13.6	5.5	16.0
36–45	7.4	22.2	18.5	16.1
46–55	27.0	34.3	39.3	18.5
56–65	46.3	19.5	30.1	19.3
66–75	10.9	5.7	5.0	12.0
> 75	3.2	0.9	0.5	7.6
Female	42.8	9.8	11.8	57.1
Race
Hispanic	8.5	14.5	12.8	9.4
White	64.5	62.6	57.1	68.7
African American	13.2	12.0	20.4	5.8
Asian	7.0	4.7	3.3	10.0
Native American/Alaska Native	1.0	0.4	0.5	0.4
Hawaiian/Pacific Islander	0.4	0.5	0.2	0.5
Multiracial	2.4	2.2	2.1	1.8
Other	0.8	0.3	0.9	0.8
Unknown	2.3	2.8	2.6	2.6
Insurance type
Medicare	28.7	20.2	30.5	25.1
Private	57.5	74.5	59.9	68.0
State subsidized	12.1	3.9	8.6	5.0
Uninsured	1.7	1.4	1.0	2.0
Tobacco use disorder	50.9	26.2	48.8	16.0
Alcohol use disorder	19.0	7.9	13.0	3.6
Other substance use disorders	19.6	10.4	26.5	2.3
Cannabis	5.9	3.1	5.5	1.1
Stimulant	7.6	6.6	20.6	0.6
Other substances	14.0	5.3	16.1	1.3
Mental health disorder diagnosis†	49.3	47.1	58.3	33.1
Non-cancer pain diagnosis	88.5	71.0	81.0	75.4
Any opioid dispensing
0 orders	35.5	52.6	36.3	59.6
1–5 orders	34.6	35.1	39.3	32.1
6–11 orders	8.6	4.9	7.6	3.4
12+ orders	21.3	7.5	16.8	4.8
Emergency department visits*
0	48.7	63.7	40.1	67.3
1	19.4	18.4	23.7	17.7
2	10.3	7.9	10.7	6.9
3+	21.6	9.9	25.5	8.1
Hospitalizations
0	72.0	85.0	69.2	86.0
1	13.8	8.7	15.9	8.5
2+	5.8	3.0	7.1	3.0
3+	8.4	3.3	7.8	2.5

*Excludes data from Health Partners

**Excludes buprenorphine

†Includes anxiety, depression, bipolar disorder, and schizophrenia